Investing Ideas
/
Italian Healthcare Undervalued based on future growth

Italian Healthcare Undervalued based on future growth

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

Svas Biosana

Market Cap: €48.5m

SVAS Biosana S.p.A. engages in the production and marketing of medical devices worldwide.

SVS

€9.12

1.3%

27.7%